Investigative Site US054 — Tempe, Arizona

Investigative Site US054 is a clinical research site located in Tempe, Arizona, United States 85282.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigative Site US054 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hidradenitis Suppurativa.

Sponsors: Incyte Corporation.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tempe

Browse all research sites in Arizona · View every site in Tempe

• Tempe St. Luke's Hospital
• Arizona State University Health Services
• Arizona State University: Prevention Research Center
• Prevention Research Center Arizona State University
• Arizona State University
• Autism/Asperger's Research Group at Arizona State University
• Gateway Building, Room 361 & 363, Arizona State University
• Celerion
• Research Site
• Clinical Research Consortium
• Alliance for Multispecialty Research
• GSK Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigative Site US054?

Investigative Site US054 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigative Site US054 conducted?

Investigative Site US054 has 1 clinical trials on record, with 1 currently active. Their work covers Hidradenitis Suppurativa.

Is Investigative Site US054 accredited by Crixeo Clinical Trials?

Investigative Site US054 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigative Site US054?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.